Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04829357 · ClinicalTrials.gov registry record

Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System

A clinical trial of Stress Urinary Incontinence, sponsored by Ethicon.

Recruiting
Registry status
195
Enrollment target
4
Study locations

NCT04829357 is a study of Stress Urinary Incontinence that is actively recruiting participants, run by Ethicon. The registered enrollment target is 195 participants, above the 157-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (24% higher). The trial reports 4 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04829357, a study of Stress Urinary Incontinence, is actively recruiting participants, sponsored by Ethicon.

RECRUITING
Registry status
195 participants
Enrollment target
4
Study locations

Study Summary

The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT ABBREVO® Continence System in women undergoing Mid-urethral sling surgery for Stress Urinary Incontinence (SUI).

Interventions

  • DEVICE Intervention

Study Locations (4)

Other

  • Bio-Medical University Rome - Rome
  • Ospedale San Pietro Fatebenefratelli - Rome
  • Ospedale Regionale Beata Vergine - Mendrisio

Pennsylvania

  • Institute for Female Pelvic Medicine - North Wales

Trial Details

FieldValue
Enrollment Target 195 participants
Start Date 2021-09-09
Est. Completion 2038-12-31

Sponsor

Ethicon

38 total trials

What the Registry Record Tells You About NCT04829357

The ClinicalTrials.gov registry entry for NCT04829357 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 157-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (24% higher). The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stress Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Intervention is the first listed.

NCT04829357 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Other, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04829357 about?

NCT04829357 is a clinical study titled "Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System". The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT ABBREVO® Continence System in women undergoing Mid-urethral sling surgery for Stress Urinary Incontinence (SUI).

What is the current status of trial NCT04829357?

This trial is currently recruiting. The enrollment target is 195 participants. The study started on 2021-09-09. Estimated completion is 2038-12-31.

What conditions does trial NCT04829357 study?

This clinical trial studies the following conditions: Stress Urinary Incontinence.

What interventions are being tested in trial NCT04829357?

The interventions under investigation include: Intervention (DEVICE).

Who is sponsoring clinical trial NCT04829357?

This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04829357 being conducted?

This trial has 4 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress Urinary Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.